BWXT: Director L. D. Melvin Sells 600 Shares at $178.27
Leland D. Melvin, identified as a director of BWX Technologies, Inc. (BWXT), reported a sale of 600 common shares on 08/11/2025 at a price of $178.265, leaving beneficial ownership of 5,579 shares.
Rhea-AI Filing Summary
Leland D. Melvin, identified as a director of BWX Technologies, Inc. (BWXT), reported a sale of 600 common shares on 08/11/2025 at a price of $178.265, leaving beneficial ownership of 5,579 shares. The Form 4 was executed by attorney-in-fact Theresa B. Taylor and signed on 08/12/2025. No derivative transactions were reported.
Positive
- None.
Negative
- None.
Insights
Insider sale of 600 shares appears routine and immaterial to shareholders.
The filing shows a direct sale of 600 shares at $178.265 on 08/11/2025, implying gross proceeds of about $106,959. The reporting person retains 5,579 shares after the transaction. There are no derivative holdings disclosed and no indication of a change in control or termination of Section 16 status in the form.
Transaction is documented and signed by attorney-in-fact; disclosure follows Section 16 reporting procedures.
The Form 4 lists the filer as a director and records a sale (transaction code S) on 08/11/2025. The signature block shows the form was executed by an attorney-in-fact, Theresa B. Taylor, on 08/12/2025. No additional schedules or derivative entries accompany this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 600 | $178.265 | $107K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did the BWXT insider report on this Form 4?
Who is the reporting person on the BWXT Form 4?
When was the Form 4 signed and by whom?
Were any derivative securities reported in this filing for BWXT?
AI-generated analysis. How Rhea-AI works. Not financial advice.